Advances in Probing Amyloid Heterogeneity Using Vibrational Spectroscopy and Imaging
Cade K Rohler1, Kayla A Hess1, Lauren E Buchanan1
1Department of Chemistry, Vanderbilt University, Nashville, Tennessee, 37235, United States.
The Journal of Physical Chemistry. B
|November 14, 2025
Summary
Protein misfolding and amyloid aggregation cause diseases. Vibrational spectroscopy, like Raman and infrared (IR) techniques, helps understand these complex processes and develop new therapies.
Area of Science:
- Biochemistry
- Biophysics
- Spectroscopy
Background:
- Protein misfolding and amyloid fibril formation are linked to various human diseases.
- Limited understanding of amyloid toxicity mechanisms due to aggregation polymorphism and biomolecular interactions.
Purpose of the Study:
- To highlight advances in vibrational spectroscopy for studying amyloid aggregation.
- To elucidate disease-related amyloid formation mechanisms and identify therapeutic targets.
Main Methods:
- Application of Raman and infrared (IR) spectroscopy and imaging.
- Integration of site-specific probes for residue-level structural information.
Main Results:
- Characterization of oligomer and fibril structures.
- Analysis of plaque compositions and coassembly effects.
- Elucidation of aggregation mechanisms under disease-relevant conditions.
Conclusions:
- Vibrational spectroscopy provides crucial insights into amyloid formation and toxicity.
- Understanding these mechanisms can lead to novel therapeutic strategies for amyloid-related diseases.
More Related Videos
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K


